Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.

A Ardizzoni; G F Addamo; E Baldini; U Borghini; L Portalone; F De Marinis; R Lionetto; P F Conte; P Bruzzi; M C Pennucci

doi:10.1038/bjc.1995.23

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.

Identifier:nobleid.org/w1/20260515/D8CDDB46

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D8CDDB46.svg?ark=w1%2F20260515%2FD8CDDB46)](https://nobleid.org/work/w1/20260515/D8CDDB46)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.

Identifier:nobleid.org/w1/20260515/D8CDDB46

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D8CDDB46.svg?ark=w1%2F20260515%2FD8CDDB46)](https://nobleid.org/work/w1/20260515/D8CDDB46)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work